{"doi":"10.1101/2020.02.19.952960","title":"Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6","abstract":"Abstract Upon target RNA recognition, type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers to activate downstream effectors including Csm6-family ribonucleases via their CARF domains. Here we show that Enteroccocus italicus Csm6 (EiCsm6) degrades its cognate cyclic hexa-AMP (cA6) activator and report the crystal structure of EiCsm6 bound to a cA6 mimic. The structure, combined with biochemical and in vivo functional assays, reveal how cA6 recognition by the CARF domain activates the Csm6 HEPN domains for collateral RNA degradation, and how CARF domain-mediated cA6 cleavage provides an intrinsic off-switch to limit Csm6 activity in the absence of ring nucleases. These mechanisms facilitate rapid invader clearance and ensure termination of CRISPR interference to limit self-toxicity.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2020,"id":120641,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9533,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":239476,"name":"Frank Schwede","orcid":"0000-0002-8185-3392","position":1,"is_corresponding":false},{"id":280761,"name":"Christian Berk","orcid":"0000-0003-3858-5764","position":2,"is_corresponding":false},{"id":280762,"name":"Jakob T. Rostøl","orcid":"0000-0001-9485-9972","position":3,"is_corresponding":false},{"id":283265,"name":"Ole Niewoehner","orcid":null,"position":4,"is_corresponding":false},{"id":280763,"name":"Oliver Tejero","orcid":"0000-0002-2905-7006","position":5,"is_corresponding":false},{"id":280764,"name":"Jonathan Hall","orcid":"0000-0003-4160-7135","position":6,"is_corresponding":false},{"id":280765,"name":"Luciano A. Marraffini","orcid":"0000-0002-9163-0969","position":7,"is_corresponding":false},{"id":280766,"name":"Martin Jínek","orcid":"0000-0002-7601-210X","position":8,"is_corresponding":false},{"id":280760,"name":"Carmela Garcia‐Doval","orcid":"0000-0002-3422-9490","position":0,"is_corresponding":true}],"reference_count":45,"raw_metadata":null,"created_at":"2026-07-18T23:14:38.147936Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}